SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-17-009411
Filing Date
2017-09-05
Accepted
2017-09-05 06:30:19
Documents
3
Period of Report
2017-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k090117_immucellcorp.htm 8-K 22672
2 LETTER OF RESIGNATION FROM THE BOARD OF DIRECTORS FROM MS. BROCKMANN TO THE COMP f8k090117ex99-1_immucellcorp.htm EX-99.1 6345
3 LETTER OF RESIGNATION FROM THE BOARD OF DIRECTORS FROM DR. CRABB TO THE COMPANY f8k090117ex99-2_immucellcorp.htm EX-99.2 5664
  Complete submission text file 0001213900-17-009411.txt   35871
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 171067368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances